Loading
  • 21 Aug, 2019

  • By, Wikipedia

Hypochondriac

Hypochondriasis or hypochondria is a condition in which a person is excessively and unduly worried about having a serious illness. Hypochondria is an old concept whose meaning has repeatedly changed over its lifespan. It has been claimed that this debilitating condition results from an inaccurate perception of the condition of body or mind despite the absence of an actual medical diagnosis. An individual with hypochondriasis is known as a hypochondriac. Hypochondriacs become unduly alarmed about any physical or psychological symptoms they detect, no matter how minor the symptom may be, and are convinced that they have, or are about to be diagnosed with, a serious illness.

Often, hypochondria persists even after a physician has evaluated a person and reassured them that their concerns about symptoms do not have an underlying medical basis or, if there is a medical illness, their concerns are far in excess of what is appropriate for the level of disease. It is also referred to hypochondriaism which is the act of being in a hypochondriatic state, acute hypochondriaism. Many hypochondriacs focus on a particular symptom as the catalyst of their worrying, such as gastro-intestinal problems, palpitations, or muscle fatigue. To qualify for the diagnosis of hypochondria the symptoms must have been experienced for at least six months.

International Classification of Diseases (ICD-10) classifies hypochondriasis as a mental and behavioral disorder. In the Diagnostic and Statistical Manual of Mental Disorders, DSM-IV-TR defined the disorder "Hypochondriasis" as a somatoform disorder and one study has shown it to affect about 3% of the visitors to primary care settings. The 2013 DSM-5 replaced the diagnosis of hypochondriasis with the diagnoses of somatic symptom disorder (75%) and illness anxiety disorder (25%).

Hypochondria is often characterized by fears that minor bodily or mental symptoms may indicate a serious illness, constant self-examination and self-diagnosis, and a preoccupation with one's body. Many individuals with hypochondriasis express doubt and disbelief in the doctors' diagnosis, and report that doctors’ reassurance about an absence of a serious medical condition is unconvincing, or short-lasting. Additionally, many hypochondriacs experience elevated blood pressure, stress, and anxiety in the presence of doctors or while occupying a medical facility, a condition known as "white coat syndrome". Many hypochondriacs require constant reassurance, either from doctors, family, or friends, and the disorder can become a debilitating challenge for the individual with hypochondriasis, as well as their family and friends. Some individuals with hypochondria completely avoid any reminder of illness, whereas others frequently visit medical facilities, sometimes obsessively. Some may never speak about it.

A research based on 41,190 people, and published in December 2023 by JAMA Psychiatry, found that people suffering from hypochondriasis had a five-year shorter life expectancy compared to those without symptoms.

Signs and symptoms

Hypochondriasis is categorized as a somatic amplification disorder—a disorder of "perception and cognition"—that involves a hyper-vigilance of situation of the body or mind and a tendency to react to the initial perceptions in a negative manner that is further debilitating. Hypochondriasis manifests in many ways. Some people have numerous intrusive thoughts and physical sensations that push them to check with family, friends, and physicians. For example, a person who has a minor cough may think that they have tuberculosis. Or sounds produced by organs in the body, such as those made by the intestines, might be seen as a sign of a very serious illness to patients dealing with hypochondriasis.

Other people are so afraid of any reminder of illness that they will avoid medical professionals for a seemingly minor problem, sometimes to the point of becoming neglectful of their health when a serious condition may exist and go undiagnosed. Yet others live in despair and depression, certain that they have a life-threatening disease and no physician can help them. Some consider the disease as a punishment for past misdeeds.

Hypochondriasis is often accompanied by other psychological disorders. Bipolar disorder, clinical depression, obsessive-compulsive disorder (OCD), phobias, and somatization disorder, panic disorder are the most common accompanying conditions in people with hypochondriasis, as well as a generalized anxiety disorder diagnosis at some point in their life.

Many people with hypochondriasis experience a cycle of intrusive thoughts followed by compulsive checking, which is very similar to the symptoms of obsessive-compulsive disorder. However, while people with hypochondriasis are afraid of having an illness, patients with OCD worry about getting an illness or of transmitting an illness to others. Although some people might have both, these are distinct conditions.

Patients with hypochondriasis often are not aware that depression and anxiety produce their own physical symptoms, and mistake these symptoms for manifestations of another mental or physical disorder or disease. For example, people with depression often experience changes in appetite and weight fluctuation, fatigue, decreased interest in sex, and motivation in life overall. Intense anxiety is associated with rapid heartbeat, palpitations, sweating, muscle tension, stomach discomfort, dizziness, shortness of breath, and numbness or tingling in certain parts of the body (hands, forehead, etc.).

If a person is ill with a medical disease such as diabetes or arthritis, there will often be psychological consequences, such as depression. Some even report being suicidal. In the same way, someone with psychological issues such as depression or anxiety will sometimes experience physical manifestations of these affective fluctuations, often in the form of medically unexplained symptoms. Common symptoms include headaches; abdominal, back, joint, rectal, or urinary pain; nausea; fever and/or night sweats; itching; diarrhea; dizziness; or balance problems. Many people with hypochondriasis accompanied by medically unexplained symptoms feel they are not understood by their physicians, and are frustrated by their doctors’ repeated failure to provide symptom relief.

Cause

The genetic contribution to hypochondriasis is probably moderate, with heritability estimates around 10–37%. Non-shared environmental factors (i.e., experiences that differ between twins in the same family) explain most of the variance in key components of the condition such as the fear of illness and disease conviction. In contrast, the contribution of shared environmental factors (i.e., experiences shared by twins in the same family) to hypochondriasis is approximately zero.

Although little is known about exactly which non-shared environmental factors typically contribute to causing hypochondriasis, certain factors such as exposure to illness-related information are widely believed to lead to short-term increases in health anxiety and to have contributed to hypochondriasis in individual cases. An excessive focus on minor health concerns and serious illness of the individual or a family member in childhood have also been implicated as potential causes of hypochondriasis. Underlying anxiety disorders, such as general anxiety disorder, also increases an individual's risk.

In the media and on the Internet, articles, TV shows, and advertisements regarding serious illnesses such as cancer and multiple sclerosis often portray these diseases as being random, obscure, and somewhat inevitable. In the short term, inaccurate portrayal of risk and the identification of non-specific symptoms as signs of serious illness may contribute to exacerbating fear of illness. Major disease outbreaks or predicted pandemics can have similar effects.

Anecdotal evidence suggests that some individuals become hypochondriac after experiencing major medical diagnosis or death of a family member or friend. Similarly, when approaching the age of a parent's premature death from disease, many otherwise healthy, happy individuals fall prey to hypochondria. These individuals believe they have the same disease that caused their parent's death, sometimes causing panic attacks with corresponding symptoms.

Diagnosis

The ICD-10 defines hypochondriasis as follows:

A. Either one of the following:
  • A persistent belief, of at least six months' duration, of the presence of a minimum of two serious physical diseases (of which at least one must be specifically named by the patient).
  • A persistent preoccupation with a presumed deformity or disfigurement (body dysmorphic disorder).
B. Preoccupation with the belief and the symptoms causes persistent distress or interference with personal functioning in daily living and leads the patient to seek medical treatment or investigations (or equivalent help from local healers).
C. Persistent refusal to accept medical advice that there is no adequate physical cause for the symptoms or physical abnormality, except for short periods of up to a few weeks at a time immediately after or during medical investigations.
D. Most commonly used exclusion criteria: not occurring only during any of the schizophrenia and related disorders (F20–F29, particularly F22) or any of the mood disorders (F30–F39).

The DSM-IV defines hypochondriasis according to the following criteria:

A. Preoccupation with fears of having, or the idea that one has, a serious disease based on the person's misinterpretation of bodily symptoms.
B. The preoccupation persists despite appropriate medical evaluation and reassurance.
C. The belief in Criterion A is not of delusional intensity (as in Delusional Disorder, Somatic Type) and is not restricted to a circumscribed concern about appearance (as in Body Dysmorphic Disorder).
D. The preoccupation causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.
E. The duration of the disturbance is at least 6 months.
F. The preoccupation is not better accounted for by Generalized Anxiety Disorder, Obsessive-Compulsive Disorder, Panic Disorder, a Major Depressive Episode, Separation Anxiety, or another Somatoform Disorder.

In the fifth version of the DSM (DSM-5), most who met criteria for DSM-IV hypochondriasis instead meet criteria for a diagnosis of somatic symptom disorder (SSD) or illness anxiety disorder (IAD).

Classification

The classification of hypochondriasis in relation to other psychiatric disorders has long been a topic of scholarly debate and has differed widely between different diagnostic systems and influential publications.

In the case of the DSM, the first and second versions listed hypochondriasis as a neurosis, whereas the third and fourth versions listed hypochondriasis as a somatoform disorder. The current version of the DSM (DSM-5) lists somatic symptom disorder (SSD) under the heading of "somatic symptom and related disorders", and illness anxiety disorder (IAD) under both this heading and as an anxiety disorder.

The ICD-10, like the third and fourth versions of the DSM, lists hypochondriasis as a somatoform disorder. The ICD-11, however, lists hypochondriasis under the heading of "obsessive-compulsive or related disorders".

There are also numerous influential scientific publications that have argued for other classifications of hypochondriasis. Notably, since the early 1990s, it has become increasingly common to regard hypochondriasis as an anxiety disorder, and to refer to the condition as "health anxiety" or "health related obsessive-compulsive disorder."

Treatment

Approximately 20 randomized controlled trials and numerous observational studies indicate that cognitive behavioral therapy (CBT) is an effective treatment for hypochondriasis. Typically, about two-thirds of patients respond to treatment, and about 50% of patients achieve remission, i.e., no longer have hypochondriasis after treatment. The effect size, or magnitude of benefit, appears to be moderate to large. CBT for hypochondriasis and health anxiety may be offered in various formats, including as face-to-face individual or group therapy, via telephone, or as guided self-help with information conveyed via a self-help book or online treatment platform. Effects are typically sustained over time.

There is also evidence that antidepressant medications such as selective serotonin reuptake inhibitors can reduce symptoms. In some cases, hypochondriasis responds well to antipsychotics, particularly the newer atypical antipsychotic medications.

Etymology

Among the regions of the abdomen, the hypochondrium is the uppermost part. The word derives from the Greek term ὑποχόνδριος hypokhondrios, meaning "of the soft parts between the ribs and navel" from ὑπό hypo ("under") and χόνδρος khondros, or cartilage (of the sternum). Hypochondria in Late Latin meant "the abdomen".

The term hypochondriasis for a state of disease without real cause reflected the ancient belief that the viscera of the hypochondria were the seat of melancholy and sources of the vapor that caused morbid feelings. Until the early 18th century, the term referred to a "physical disease caused by imbalances in the region that was below your rib cage" (i.e., of the stomach or digestive system). For example, Robert Burton's The Anatomy of Melancholy (1621) blamed it "for everything from 'too much spittle' to 'rumbling in the guts'".

Immanuel Kant discussed hypochondria in his 1798 book, Anthropology from a Pragmatic Point of View, like this:

The disease of the hypochondriac consists in this: that certain bodily sensations do not so much indicate a really existing disease in the body as rather merely excite apprehensions of its existence: and human nature is so constituted – a trait which the animal lacks – that it is able to strengthen or make permanent local impressions simply by paying attention to them, whereas an abstraction – whether produced on purpose or by other diverting occupations – lessens these impressions, or even effaces them altogether.

See also

References

  1. ^ Berrios GE (2001) Hypochondriasis. History of the Concept. In Starcevic V & Lipsitt DR (eds). Hypochondriasis. Oxford, Oxford University Press, pp3-20.
  2. ^ Avia MD, Ruiz MA (2005). "Recommendations for the Treatment of Hypochondriac Patients". Journal of Contemporary Psychotherapy. 35 (3): 301–13. doi:10.1007/s10879-005-4322-3. S2CID 28529570.
  3. ^ Kring AM, Davison GC, Neale JM, Johnson SL (2007). Abnormal Psychology with Cases (10th ed.). Wiley. ISBN 978-0-471-71260-2.
  4. ^ Shan-Tilly
  5. ^ Goldberg RJ (2007). Practical Guide to the Care of the Psychiatric Patient. Mosby/Elsevier. ISBN 978-0-323-03683-2.
  6. ^ Drs; Sartorius N, Henderson A, Strotzka H, Lipowski Z, Yu-cun S, You-xin X, Strömgren E, Glatzel J, Kühne GE, Misès R, Soldatos C, Pull C, Giel R, Jegede R, Malt U, Nadzharov R, Smulevitch A, Hagberg B, Perris C, Scharfetter C, Clare A, Cooper J, Corbett J, Griffith Edwards J, Gelder M, Goldberg D, Gossop M, Graham P, Kendell R, Marks I, Russell G, Rutter M, Shepherd M, West D, Wing J, Wing L, Neki J, Benson F, Cantwell D, Guze S, Helzer J, Holzman P, Kleinman A, Kupfer D, Mezzich J, Spitzer R, Lokar J. "The ICD-10 Classification of Mental and Behavioural Disorders Clinical descriptions and diagnostic guidelines" (PDF). www.who.int World Health Organization. Microsoft Word. bluebook.doc. p. 116. Retrieved 23 June 2021 – via Microsoft Bing.
  7. ^ American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text revised, Washington, DC, APA, 2000.
  8. ^ Escobar JI, Gara M, Waitzkin H, Silver RC, Holman A, Compton W (May 1998). "DSM-IV hypochondriasis in primary care" (PDF). General Hospital Psychiatry. 20 (3): 155–9. doi:10.1016/S0163-8343(98)00018-8. PMID 9650033. S2CID 597107.
  9. ^ "DSM-5 redefines hypochondriasis - Mayo Clinic". Mayo Clinic.
  10. ^ Diagnostic and statistical manual of mental disorders : DSM-5 (5th ed.). American Psychiatric Association. 2013. p. 310. ISBN 978-0-89042-554-1.
  11. ^ Olatunji BO, Etzel EN, Tomarken AJ, Ciesielski BG, Deacon B (November 2011). "The effects of safety behaviors on health anxiety: an experimental investigation". Behaviour Research and Therapy. 49 (11): 719–28. doi:10.1016/j.brat.2011.07.008. PMID 21839987.
  12. ^ "Illness anxiety disorder". Mayo Clinic. Retrieved January 2, 2023.
  13. ^ Mataix-Cols D, Isomura K, Sidorchuk A (2024). "All-Cause and Cause-Specific Mortality Among Individuals With Hypochondriasis". JAMA Psychiatry. 81 (3): 284–291. doi:10.1001/jamapsychiatry.2023.4744. PMC 10719832. PMID 38091000. Retrieved 24 January 2024.
  14. ^ Schacter DL, Gilbert DT, Wegner DM (2011). "Generalized Anxiety Disorder". Psychology (second ed.). Macmillan. ISBN 978-1-4292-3719-2.
  15. ^ French JH, Hameed S (2022). "Illness Anxiety Disorder". StatPearls. StatPearls Publishing. PMID 32119286.
  16. ^ Fallon BA, Qureshi AI, Laje G, Klein B (September 2000). "Hypochondriasis and its relationship to obsessive-compulsive disorder". The Psychiatric Clinics of North America. 23 (3): 605–16. doi:10.1016/S0193-953X(05)70183-0. PMID 10986730.
  17. ^ Barsky AJ (December 1992). "Hypochondriasis and obsessive compulsive disorder". The Psychiatric Clinics of North America. 15 (4): 791–801. doi:10.1016/S0193-953X(18)30209-0. PMID 1461796.
  18. ^ "Depression". National Institute of Mental Health.
  19. ^ "Anxiety Disorders". National Institute of Mental Health.
  20. ^ "Mental Health | ADA". www.diabetes.org. Archived from the original on 2019-09-15. Retrieved 2019-10-10.
  21. ^ Gelenberg AJ (April 2000). "Psychiatric and Somatic Markers of Anxiety: Identification and Pharmacologic Treatment". Primary Care Companion to the Journal of Clinical Psychiatry. 2 (2): 49–54. doi:10.4088/pcc.v02n0204. PMC 181205. PMID 15014583.
  22. ^ "Illness Anxiety Disorder". The Lecturio Medical Concept Library. Retrieved 2021-06-24.
  23. ^ Taylor S, Thordarson DS, Jang KL, Asmundson GJ (2006). "Genetic and environmental origins of health anxiety: a twin study". World Psychiatry. 5 (1): 47–50. PMC 1472263. PMID 16757996.
  24. ^ Kancherla N, Vanka SC, Pokhrel S, Shahzadi RB, Vijaya Durga Pradeep G (27 May 2022). "The Development of Illness Anxiety Disorder in a Patient After Partial Thyroidectomy". Cureus. 14 (5): e25416. doi:10.7759/cureus.25416. PMC 9233939. PMID 35769682. (Retracted, see doi:10.7759/cureus.r59, PMID 38348430. If this is an intentional citation to a retracted paper, please replace {{retracted|...}} with {{retracted|...|intentional=yes}}.)
  25. ^ Scarella TM, Laferton JA, Ahern DK, Fallon BA, Barsky A (2016-03-01). "The Relationship of Hypochondriasis to Anxiety, Depressive, and Somatoform Disorders". Psychosomatics. 57 (2): 200–207. doi:10.1016/j.psym.2015.10.006. ISSN 0033-3182. PMC 4792743. PMID 26785798.
  26. ^ Pavithra N, Dahale AB, Desai G, Chaturvedi SK (2019). "Hypochondriasis: Clinical Profile in a Tertiary Care Psychiatry and Neurosciences Hospital in Southern India – A Retrospective Chart Review". Indian Journal of Psychological Medicine. 41 (2): 178–181. doi:10.4103/IJPSYM.IJPSYM_177_18. ISSN 0253-7176. PMC 6436408. PMID 30983668.
  27. ^ "ICD-11 for Mortality and Morbidity Statistics". icd.who.int. Retrieved 2023-12-30.
  28. ^ Axelsson E, Hedman-Lagerlöf E (2023-02-01). "Validity and clinical utility of distinguishing between DSM-5 somatic symptom disorder and illness anxiety disorder in pathological health anxiety: Should we close the chapter?". Journal of Psychosomatic Research. 165: 111133. doi:10.1016/j.jpsychores.2022.111133. ISSN 0022-3999. PMID 36624001.
  29. ^ Olatunji BO, Kauffman BY, Meltzer S, Davis ML, Smits JA, Powers MB (July 2014). "Cognitive-behavioral therapy for hypochondriasis/health anxiety: a meta-analysis of treatment outcome and moderators". Behaviour Research and Therapy. 58: 65–74. doi:10.1016/j.brat.2014.05.002. PMID 24954212. S2CID 10465353.
  30. ^ Bouman TK (February 2014). "Psychological Treatments for Hypochondriasis: A Narrative Review". Current Psychiatry Reviews. 10 (1): 58–69. doi:10.2174/1573400509666131119010612.
  31. ^ Cooper K, Gregory JD, Walker I, Lambe S, Salkovskis PM (March 2017). "Cognitive Behaviour Therapy for Health Anxiety: A Systematic Review and Meta-Analysis" (PDF). Behavioural and Cognitive Psychotherapy. 45 (2): 110–123. doi:10.1017/S1352465816000527. PMID 28229805.
  32. ^ Axelsson E, Hedman-Lagerlöf E (2 November 2019). "Cognitive behavior therapy for health anxiety: systematic review and meta-analysis of clinical efficacy and health economic outcomes" (PDF). Expert Review of Pharmacoeconomics & Outcomes Research. 19 (6): 663–676. doi:10.1080/14737167.2019.1703182. PMID 31859542.
  33. ^ Morriss R, Patel S, Malins S, Guo B, Higton F, James M, Wu M, Brown P, Boycott N, Kaylor-Hughes C, Morris M, Rowley E, Simpson J, Smart D, Stubley M, Kai J, Tyrer H (December 2019). "Clinical and economic outcomes of remotely delivered cognitive behaviour therapy versus treatment as usual for repeat unscheduled care users with severe health anxiety: a multicentre randomised controlled trial". BMC Medicine. 17 (1): 16. doi:10.1186/s12916-019-1253-5. PMC 6343350. PMID 30670044.
  34. ^ Axelsson E, Andersson E, Ljótsson B, Hedman-Lagerlöf E (August 2018). "Cost-effectiveness and long-term follow-up of three forms of minimal-contact cognitive behaviour therapy for severe health anxiety: Results from a randomised controlled trial". Behaviour Research and Therapy. 107: 95–105. doi:10.1016/j.brat.2018.06.002. hdl:10616/46521. PMID 29936239. S2CID 49406483.
  35. ^ Axelsson E, Andersson E, Ljótsson B, Björkander D, Hedman-Lagerlöf M, Hedman-Lagerlöf E (2020). "Effect of Internet vs Face-to-Face Cognitive Behavior Therapy for Health Anxiety: A Randomized Noninferiority Clinical Trial". JAMA Psychiatry. 77 (9): 915–924. doi:10.1001/jamapsychiatry.2020.0940. PMC 7221860. PMID 32401286.
  36. ^ Tyrer P, Wang D, Crawford M, Dupont S, Cooper S, Nourmand S, Lazarevic V, Philip A, Tyrer H (July 2021). "Sustained benefit of cognitive behaviour therapy for health anxiety in medical patients (CHAMP) over 8 years: a randomised-controlled trial". Psychological Medicine. 51 (10): 1714–1722. doi:10.1017/S003329172000046X. hdl:10044/1/77505. PMID 32174296. S2CID 212731146.
  37. ^ Louw KA, Hoare J, Stein DJ (February 2014). "Pharmacological Treatments for Hypochondriasis: A Review". Current Psychiatry Reviews. 10 (1): 70–4. doi:10.2174/1573400509666131119004750.
  38. ^ Fallon BA, Ahern DK, Pavlicova M, Slavov I, Skritskya N, Barsky AJ (August 2017). "A Randomized Controlled Trial of Medication and Cognitive-Behavioral Therapy for Hypochondriasis". American Journal of Psychiatry. 174 (8): 756–764. doi:10.1176/appi.ajp.2017.16020189. PMC 5957509. PMID 28659038.
  39. ^ Harth W, Gieler U, Kusnir D, Tausk FA (2008). "Hypochondriacal Delusions". Clinical Management in Psychodermatology. Springer. p. 36. ISBN 978-3-540-34718-7.
  40. ^ "hypochondria (n.)". Etymonline. Retrieved 14 April 2015.
  41. ^ Chappell AS (2018-04-27). "Toward a Lifestyle Medicine Approach to Illness Anxiety Disorder (Formerly Hypochondriasis)". American Journal of Lifestyle Medicine. 12 (5): 365–369. doi:10.1177/1559827618764649. ISSN 1559-8276. PMC 6146366. PMID 30283260.
  42. ^ Mann L (July 11, 2012). "New book tries to explain the roots of hypochondria". Chicago Tribune.

Further reading

Listen to this article (6 minutes)
Spoken Wikipedia icon
This audio file was created from a revision of this article dated 18 December 2006 (2006-12-18), and does not reflect subsequent edits.